Konami Group Corporation - KONMY

KONMY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
KONMY	0	0	-9.6	8.8	20.3	64.4	51.4	43.9	43.9	43.9
S&P 500	-1.1	-1.5	1.2	6.2	10.9	30.7	25.7	88.6	188.3	33219.0

Compare KONMY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	KONMY
name	Konami Group Corporation
price	43.16
changes percentage	0
change	0
day low	43.16
day high	43.74
year high	49.50
year low	39.66
market cap	13117185474
price avg 50	46.51
price avg 200	45.59
exchange	PNK
volume	100
avg volume	47
open	43.74
previous close	None
eps	1.66
pe	26
earnings announcement	2025-01-30T00:00:00.000+0000
shares outstanding	303919960
timestamp	2024-11-14 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 70.0%

Overall Quarterly Financial Health: 55.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	360314000000	314321000000	14.63
gross profit	160037000000	122391000000	30.76
gross profit ratio	0.44	0.39	14.07
research and development expenses	54194000000	51081000000	6.09
operating expenses	71825000000	65780000000	9.19
interest income	2814000000	363000000	675.21
interest expense	665000000	752000000	-11.57
ebitda	103529000000	70030000000	47.84
ebitdaratio	0.29	0.26	12.25
operating income	88212000000	56611000000	55.82
operating income ratio	0.24	0.18	35.93
net income	59171000000	34895000000	69.57
net income ratio	0.16	0.11	47.92
eps	436.5	258.81	68.66

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 360,314 million in 2024 from 314,321 million in 2023 representing a change of 14.63%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 160,037 million in 2024 from 122,391 million in 2023 representing a change of 30.76%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 54,194 million in 2024 from 51,081 million in 2023 representing a change of 6.09%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 88,212 million in 2024 from 56,611 million in 2023 representing a change of 55.82%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 59,171 million in 2024 from 34,895 million in 2023 representing a change of 69.57%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 436.5 in 2024 from 436.5 in 2023 representing a change of 68.66%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 71,825 million in 2024 from 65,780 million in 2023 representing a change of 9.19%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 103,529 million in 2024 from 70,030 million in 2023 representing a change of 47.84%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
revenue	90039000000	107218000000	-16.02
gross profit	43737000000	47673000000	-8.26
gross profit ratio	0.49	0.44	9.25
research and development expenses	0	14262000000	-100.00
operating expenses	18588000000	22282000000	-16.58
interest income	1426000000	802000000	77.81
interest expense	157000000	176000000	-10.80
ebitda	29721000000	27966000000	6.28
ebitdaratio	0.33	0.31	8.22
operating income	25149000000	25391000000	-0.95
operating income ratio	0.28	0.24	17.94
net income	19160000000	14676000000	30.55
net income ratio	0.21	0.14	55.46
eps	141.34	108.26	30.56

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 90,039 million in 2025Q1 from 107,218 million in 2024Q4 representing a change of -16.02%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 18,588 million in 2025Q1 from 22,282 million in 2024Q4 representing a change of -16.58%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 29,721 million in 2025Q1 from 27,966 million in 2024Q4 representing a change of 6.28%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 19,160 million in 2025Q1 from 14,676 million in 2024Q4 representing a change of 30.55%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 141.34 in 2025Q1 from 141.34 in 2024Q4 representing a change of 30.56%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 43,737 million in 2025Q1 from 47,673 million in 2024Q4 representing a change of -8.26%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2025Q1 from 14,262 million in 2024Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Income: Operating income decreased to 25,149 million in 2025Q1 from 25,391 million in 2024Q4 representing a change of -0.95%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	605850000000	547223000000	10.71
total liabilities	178472000000	170944000000	4.40
total equity	427378000000	376279000000	13.58
cash and cash equivalents	268313000000	219263000000	22.37
short term investments	5434000000	2157000000	151.92
long term investments	22035000000	5129000000	329.62
total current assets	343860000000	290041000000	18.56
total non current assets	261990000000	257182000000	1.87
total current liabilities	85926000000	75094000000	14.42
total non current liabilities	92546000000	95850000000	-3.45
common stock	47399000000	47399000000	0.00
retained earnings	302797000000	260435000000	16.27
total debt	59862000000	89460000000	-33.09

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 605,850 million in 2024 from 547,223 million in 2023 representing a change of 10.71%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 427,378 million in 2024 from 376,279 million in 2023 representing a change of 13.58%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 268,313 million in 2024 from 219,263 million in 2023 representing a change of 22.37%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 5,434 million in 2024 from 2,157 million in 2023 representing a change of 151.92%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 343,860 million in 2024 from 290,041 million in 2023 representing a change of 18.56%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 302,797 million in 2024 from 260,435 million in 2023 representing a change of 16.27%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 59,862 million in 2024 from 89,460 million in 2023 representing a change of -33.09%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 178,472 million in 2024 from 170,944 million in 2023 representing a change of 4.4%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 85,926 million in 2024 from 75,094 million in 2023 representing a change of 14.42%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
total assets	612599000000	605850000000	1.11
total liabilities	170451000000	178472000000	-4.49
total equity	442148000000	427378000000	3.46
cash and cash equivalents	273863000000	268313000000	2.07
short term investments	18329000000	5434000000	237.30
long term investments	6172000000	5224000000	18.15
total current assets	341519000000	343860000000	-0.68
total non current assets	271080000000	261990000000	3.47
total current liabilities	78704000000	85926000000	-8.40
total non current liabilities	91747000000	92546000000	-0.86
common stock	47399000000	47399000000	0.00
retained earnings	312604000000	302797000000	3.24
total debt	59873000000	87285000000	-31.41

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 612,599 million in 2025Q1 from 605,850 million in 2024Q4 representing a change of 1.11%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 170,451 million in 2025Q1 from 178,472 million in 2024Q4 representing a change of -4.49%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 442,148 million in 2025Q1 from 427,378 million in 2024Q4 representing a change of 3.46%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 273,863 million in 2025Q1 from 268,313 million in 2024Q4 representing a change of 2.07%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 18,329 million in 2025Q1 from 5,434 million in 2024Q4 representing a change of 237.3%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 78,704 million in 2025Q1 from 85,926 million in 2024Q4 representing a change of -8.4%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 312,604 million in 2025Q1 from 302,797 million in 2024Q4 representing a change of 3.24%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 59,873 million in 2025Q1 from 87,285 million in 2024Q4 representing a change of -31.41%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Assets: Total Current Assets decreased to 341,519 million in 2025Q1 from 343,860 million in 2024Q4 representing a change of -0.68%. This indicates a worsen liquidity position.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	49050000000	-31448000000	255.97
operating cash flow	103061000000	36098000000	185.50
free cash flow	73745000000	-7681000000	1,060.10
capital expenditure	-29316000000	-43779000000	33.04
depreciation and amortization	23267000000	23845000000	-2.42
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	3288000000	478000000	587.87
inventory	293000000	-3309000000	108.85
acquisitions net	0	0	NaN
investments in property plant and equipment	-29316000000	-43779000000	33.04
net cash used for investing activites	-29216000000	-42786000000	31.72
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-16796000000	-20000000000	16.02
net cash used provided by financing activities	-24199000000	-27467000000	11.90
cash at end of period	268313000000	219263000000	22.37
accounts receivables	-2218000000	-8749000000	74.65
cash at beginning of period	219263000000	250711000000	-12.54

Overall Score of Annual Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 49,050 million in 2024 from -31,448 million in 2023 representing a change of 255.97%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 103,061 million in 2024 from 36,098 million in 2023 representing a change of 185.5%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 73,745 million in 2024 from -7,681 million in 2023 representing a change of 1060.1%. This indicates an increase in cash generated after accounting for capital expenditures.

  Dividends Paid: Dividends Paid increased to -16,796 million in 2024 from -20,000 million in 2023 representing a change of 16.02%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -29,316 million in 2024 from -43,779 million in 2023 representing a change of 33.04%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 3,288 million in 2024 from 478 million in 2023 representing a change of 587.87%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -2,218 in 2024 from -8,749 million in 2023 representing a change of 74.65%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000000000
operating cash flow	18660000000	38567000000	-51.62
free cash flow	9219000000	34749000000	-73.47
capital expenditure	-9441000000	-3818000000	-147.28
depreciation and amortization	4572000000	7312000000	-37.47
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	7760000000	1186000000	554.30
accounts payables	-4311000000	2146000000	-300.89
inventory	-1000000	2935000000	-100.03
acquisitions net	0	0	NaN
investments in property plant and equipment	-9441000000	-3818000000	-147.28
net cash used for investing activites	-10361000000	-3844000000	-169.54
debt repayment	-1844000000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-9318000000	-7000000	-133,014.29
net cash used provided by financing activities	-11163000000	-1840000000	-506.68
net change in cash	5550000000	30030000000	-81.52
cash at end of period	273863000000	268313000000	2.07
cash at beginning of period	268313000000	238283000000	12.60

Overall Score of Quarterly Cashflow Statement

0.14 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 5,550 million in 2025Q1 from 30,030 million in 2024Q4 representing a change of -81.52%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 18,660 million in 2025Q1 from 38,567 million in 2024Q4 representing a change of -51.62%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 9,219 million in 2025Q1 from 34,749 million in 2024Q4 representing a change of -73.47%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables increased to 4,311 million in 2025Q1 from 2,146 million in 2024Q4 representing a change of -300.89%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 7,760 in 2025Q1 from 1,186 million in 2024Q4 representing a change of 554.3%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -9,318 million in 2025Q1 from -7 million in 2024Q4 representing a change of -133014.29%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -9,441 million in 2025Q1 from -3,818 million in 2024Q4 representing a change of -147.28%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-03-31	2023-03-31	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	2658.0	2331.23	14.02
net income per share	436.5	258.81	68.66
operating cash flow per share	760.27	267.73	183.97
free cash flow per share	544.01	-56.97	1,054.94
cash per share	2019.4	1642.21	22.97
book value per share	3152.72	2790.76	12.97
tangible book value per share	2730.57	2423.24	12.68
shareholders equity per share	3152.6	2790.65	12.97
interest debt per share	446.5	449.24	-0.61
market cap	689665356852.01	411602685459.37	67.56
enterprise value	481214356852.01	281799685459.37	70.76
pe ratio	11.66	11.8	-1.19
price to sales ratio	1.91	1.31	46.17
pocfratio	6.69	11.4	-41.31
pfcf ratio	9.35	-53.59	117.45
pb ratio	1.61	1.09	47.52
ptb ratio	1.61	1.09	47.52
ev to sales	1.34	0.9	48.97
enterprise value over ebitda	4.65	4.02	15.51
ev to operating cash flow	4.67	7.81	-40.19
ev to free cash flow	6.53	-36.69	117.79
earnings yield	0.09	0.08	1.20
free cash flow yield	0.11	-0.02	673.00
debt to equity	0.14	0.16	-11.89
debt to assets	0.1	0.11	-9.61
net debt to ebitda	-2.01	-1.85	-8.63
current ratio	4.0	3.86	3.61
interest coverage	132.65	75.28	76.21
income quality	1.74	1.03	68.37
dividend yield	0.02	0.05	-49.88
payout ratio	0.28	0.57	-50.47
sales general and administrative to revenue	0.2	0.21	-4.75
research and ddevelopement to revenue	0.15	0.16	-7.45
intangibles to total assets	0.09	0.09	4.31
capex to operating cash flow	0.28	1.21	-76.55
capex to revenue	0.08	0.14	-41.58
capex to depreciation	1.26	1.84	-31.37
stock based compensation to revenue	0	0	NaN
graham number	5564.39	4031.17	38.03
roic	0.13	0.1	34.73
return on tangible assets	0.11	0.07	53.82
graham net net	996.41	639.96	55.70
working capital	257934000000	214947000000	20.00
tangible asset value	370152000000	326726000000	13.29
net current asset value	165388000000	119097000000	38.87
invested capital	469614000000	420288000000	11.74
average receivables	41581500000	34165000000	21.71
average payables	40907500000	35522000000	15.16
average inventory	13234500000	10831000000	22.19
days sales outstanding	44.46	45.61	-2.52
days payables outstanding	80.66	71.43	12.93
days of inventory on hand	25.08	24.16	3.82
receivables turnover	8.21	8.0	2.59
payables turnover	4.53	5.11	-11.45
inventory turnover	14.55	15.11	-3.68
roe	0.14	0.09	49.29
capex per share	216.26	324.7	-33.40

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 11.66 on 2024-03-31 from 11.80 on 2023-03-31, representing a change of -1.19%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 4.00 on 2024-03-31 from 3.86 on 2023-03-31, representing a change of 3.61%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.14 on 2024-03-31 from 0.16 on 2023-03-31, representing a change of -11.89%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q1	2024-03-31 Q4	Q/Q change %
KONMY
calendar year	2025	2024	NaN
revenue per share	664.21	790.94	-16.02
net income per share	141.34	108.26	30.55
operating cash flow per share	137.65	284.51	-51.62
free cash flow per share	68.01	256.34	-73.47
cash per share	2155.48	2019.41	6.74
book value per share	3261.69	3152.74	3.46
tangible book value per share	2803.15	2730.58	2.66
shareholders equity per share	3261.58	3152.62	3.46
interest debt per share	442.84	498.13	-11.10
market cap	730234534256.76	689662558678.01	5.88
enterprise value	516244534256.76	508634558678.01	1.50
pe ratio	9.53	11.75	-18.90
price to sales ratio	8.11	6.43	26.08
pocfratio	39.13	17.88	118.84
pfcf ratio	79.21	19.85	299.10
pb ratio	1.65	1.61	2.35
ptb ratio	1.65	1.61	2.35
ev to sales	5.73	4.74	20.86
enterprise value over ebitda	17.37	18.19	-4.50
ev to operating cash flow	27.67	13.19	109.78
ev to free cash flow	56.0	14.64	282.57
earnings yield	0.03	0.02	23.30
free cash flow yield	0.01	0.05	-74.94
debt to equity	0.14	0.16	-14.07
debt to assets	0.1	0.11	-12.08
net debt to ebitda	-7.2	-6.47	-11.23
current ratio	4.34	4.0	8.43
interest coverage	160.18	144.27	11.03
income quality	0.97	2.63	-62.94
dividend yield	0.01	0.0	125,618.43
payout ratio	0.49	0.0	101,861.65
sales general and administrative to revenue	0.21	0.21	-0.66
research and ddevelopement to revenue	0	0.13	-100.00
intangibles to total assets	0.1	0.09	7.42
capex to operating cash flow	0.51	0.1	411.08
capex to revenue	0.1	0.04	194.46
capex to depreciation	2.06	0.52	295.47
stock based compensation to revenue	0	0	NaN
graham number	3220.63	2771.2	16.22
roic	0.04	0.04	1.29
return on tangible assets	0.03	0.03	30.12
graham net net	1155.92	996.42	16.01
working capital	262815000000	257934000000	1.89
tangible asset value	379989000000	370152000000	2.66
net current asset value	171068000000	165388000000	3.43
invested capital	479036000000	469614000000	2.01
average receivables	40442000000	43808500000	-7.68
average payables	41733000000	41041000000	1.69
average inventory	14087500000	14918500000	-5.57
days sales outstanding	36.98	36.84	0.38
days payables outstanding	76.21	66.89	13.93
days of inventory on hand	28.01	20.8	34.65
receivables turnover	2.43	2.44	-0.38
payables turnover	1.18	1.35	-12.23
inventory turnover	3.21	4.33	-25.73
roe	0.04	0.03	26.19
capex per share	69.65	28.17	147.28

• Negative

  ROE: Return on Equity (ROE) increased to 0.04 on 2024-06-30 Q1 from 0.03 on 2024-03-31 Q4, representing a change of 26.19%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 9.53 on 2024-06-30 Q1 from 11.75 on 2024-03-31 Q4, representing a change of -18.90%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 4.34 on 2024-06-30 Q1 from 4.00 on 2024-03-31 Q4, representing a change of 8.43%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.14 on 2024-06-30 Q1 from 0.16 on 2024-03-31 Q4, representing a change of -14.07%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 52.73 which is higher than current price 43.16, indicates the company may be undervalued.